Palani Santhosh Insider Trades

Insider Trading History

Track insider trading activity for Palani Santhosh. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Acrivon Therapeutics
Acrivon Therapeutics ACRV
Director
Holding Value $14.1k 9,366 shares
Last Trade
May 18, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$15.5k 9,366 shares
$1.65
$1.51
Pyxis Oncology
Pyxis Oncology PYXS
Director
Holding Value $78k 45,867 shares
Last Trade
Mar 24, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$62.4k 45,867 shares
$1.36
$1.70
Acrivon Therapeutics
Acrivon Therapeutics ACRV
Director
Holding Value $30.6k 20,275 shares
Last Trade
Jun 13, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24.3k 20,275 shares
$1.20
$1.51
Pyxis Oncology
Pyxis Oncology PYXS
Director
Holding Value $62.9k 36,979 shares
Last Trade
Mar 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$36.2k 36,979 shares
$0.98
$1.70
Pyxis Oncology
Pyxis Oncology PYXS
Director
Holding Value $10.2k 6,000 shares
Last Trade
Jun 07, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.8k 6,000 shares
$3.80
$1.70
Pyxis Oncology
Pyxis Oncology PYXS
Director
Holding Value $119k 69,760 shares
Last Trade
Mar 12, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$398k 69,760 shares
$5.70
$1.70
Acrivon Therapeutics
Acrivon Therapeutics ACRV
Director
Holding Value $49.1k 32,500 shares
Last Trade
Mar 04, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$164k 32,500 shares
$5.05
$1.51

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up